GENNEX LABORATORIES
Back to Income Statement
|
GENNEX LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹138 Cr | ₹87 Cr | ₹66 Cr | ₹61 Cr | ₹60 Cr |
What is the latest Revenue of GENNEX LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹138 Cr |
| Mar2025 | ₹87 Cr |
| Mar2024 | ₹66 Cr |
| Mar2023 | ₹61 Cr |
| Mar2022 | ₹60 Cr |
How is Revenue of GENNEX LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹138 Cr | 59.03 | |
| Mar2025 | ₹87 Cr | 32.18 | |
| Mar2024 | ₹66 Cr | 7.17 | |
| Mar2023 | ₹61 Cr | 2.62 | |
| Mar2022 | ₹60 Cr | - | |
Compare Revenue of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹208.7 Cr | -4.2% | -16.8% | -38% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -0.1% | -6.5% | 3.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,780.0 Cr | -0.2% | -5.5% | 35.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,828.0 Cr | 0.4% | -8.2% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,305.0 Cr | 1.7% | -2% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,759.0 Cr | 4.9% | 7.7% | -2.5% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -4.2% |
-16.8% |
-38% |
| SENSEX | -1.5% |
-1.2% |
-11.8% |
You may also like the below Video Courses